118 related articles for article (PubMed ID: 19351607)
1. Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone- secreting adrenal phaeochromocytoma: review of the literature and report of a case.
Ruggeri RM; Ferraù F; Campennì A; Simone A; Barresi V; Giuffrè G; Tuccari G; Baldari S; Trimarchi F
Eur J Histochem; 2009; 53(1):1-6. PubMed ID: 19351607
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical localization and functional characterization of somatostatin receptor subtypes in a corticotropin releasing hormone-secreting adrenal phaeochromocytoma: review of the literature and report of a case.
Ruggeri RM; Ferraù F; Campennì A; Simone A; Barresi V; Giuffrè G; Tuccari G; Baldari S; Trimarchi F
Eur J Histochem; 2009 Mar; 53(1):e1. PubMed ID: 30256857
[TBL] [Abstract][Full Text] [Related]
3. An unusual case of ectopic corticotrophin-releasing hormone syndrome caused by an adrenal noncatecholamine-secreting pheochromocytoma: a case report.
Wang BP; Yang LL; Wang H; He Q; Ma ZS; Lin Y; Jiang CX; Sun HR; Liu M
BMC Endocr Disord; 2018 Jun; 18(1):41. PubMed ID: 29921267
[TBL] [Abstract][Full Text] [Related]
4. Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy.
Mundschenk J; Unger N; Schulz S; Höllt V; Schulz S; Steinke R; Lehnert H
J Clin Endocrinol Metab; 2003 Nov; 88(11):5150-7. PubMed ID: 14602742
[TBL] [Abstract][Full Text] [Related]
5. Somatostatin receptor scintigraphy: its value in tumor localization in patients with Cushing's syndrome caused by ectopic corticotropin or corticotropin-releasing hormone secretion.
de Herder WW; Krenning EP; Malchoff CD; Hofland LJ; Reubi JC; Kwekkeboom DJ; Oei HY; Pols HA; Bruining HA; Nobels FR
Am J Med; 1994 Apr; 96(4):305-12. PubMed ID: 8166148
[TBL] [Abstract][Full Text] [Related]
6. Cushing's syndrome due to ectopic CRH secretion by adrenal pheochromocytoma accompanied by renal infarction.
Bayraktar F; Kebapcilar L; Kocdor MA; Asa SL; Yesil S; Canda S; Demir T; Saklamaz A; Seçil M; Akinci B; Yener S; Comlekci A
Exp Clin Endocrinol Diabetes; 2006 Sep; 114(8):444-7. PubMed ID: 17039427
[TBL] [Abstract][Full Text] [Related]
7. Does the response of GH-secreting pituitary adenomas to octreotide depend on the cellular localization of the somatostatin receptor subtypes SSTR2 and SSTR5?
Pisarek H; Pawlikowski M; Kunert-Radek J; Winczyk K
Endokrynol Pol; 2010; 61(2):178-81. PubMed ID: 20464704
[TBL] [Abstract][Full Text] [Related]
8. Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas.
Elston MS; Meyer-Rochow GY; Conaglen HM; Clarkson A; Clifton-Bligh RJ; Conaglen JV; Gill AJ
Hum Pathol; 2015 Mar; 46(3):390-6. PubMed ID: 25554089
[TBL] [Abstract][Full Text] [Related]
9. The biology and clinical relevance of somatostatin receptor scintigraphy in adrenal tumor management.
Kennedy JW; Dluhy RG
Yale J Biol Med; 1997; 70(5-6):565-75. PubMed ID: 9825485
[TBL] [Abstract][Full Text] [Related]
10. Somatostatin analog challenge test in the pre-surgical management of ACTH-secreting pheochromocytoma.
Rossini A; Perticone F; Frosio L; Schiavo Lena M; Lanzi R
Endocrinol Diabetes Metab Case Rep; 2019 Nov; 2019():. PubMed ID: 31765327
[TBL] [Abstract][Full Text] [Related]
11. [Somatostatin receptors expression (SSTR1-SSTR5) in pheochromocytomas].
Hubalewska-Dydejczyk A; Trofimiuk M; Sowa-Staszczak A; Gilis-Januszewska A; Wierzchowski W; Pach D; Budzyński A; Karcz D
Przegl Lek; 2008; 65(9):405-7. PubMed ID: 19140390
[TBL] [Abstract][Full Text] [Related]
12. Frequency of Cushing's syndrome due to ACTH-secreting adrenal medullary lesions: a retrospective study over 10 years from a single center.
Falhammar H; Calissendorff J; Höybye C
Endocrine; 2017 Jan; 55(1):296-302. PubMed ID: 27699708
[TBL] [Abstract][Full Text] [Related]
13. Cushing's syndrome due to ACTH-secreting pheochromocytoma.
Brenner N; Kopetschke R; Ventz M; Strasburger CJ; Quinkler M; Gerl H
Can J Urol; 2008 Feb; 15(1):3924-7. PubMed ID: 18304406
[TBL] [Abstract][Full Text] [Related]
14. Immunoreactive corticotropin-releasing hormone, growth hormone-releasing hormone, somatostatin, and peptide histidine methionine are present in adrenal pheochromocytomas, but not in extra-adrenal pheochromocytoma.
Sasaki A; Yumita S; Kimura S; Miura Y; Yoshinaga K
J Clin Endocrinol Metab; 1990 Apr; 70(4):996-9. PubMed ID: 1969422
[TBL] [Abstract][Full Text] [Related]
15. [Pheochromocytoma--pathohistologic and immunohistochemical aspects].
Tatić S; Havelka M; Paunović I; Bozić V; Diklic A; Brasanac D; Janković R; Jancić-Zguricas M
Srp Arh Celok Lek; 2002 Jul; 130 Suppl 2():7-13. PubMed ID: 12584991
[TBL] [Abstract][Full Text] [Related]
16. Variable somatostatin receptor subtype expression in 151 primary pheochromocytomas and paragangliomas.
Leijon H; Remes S; Hagström J; Louhimo J; Mäenpää H; Schalin-Jäntti C; Miettinen M; Haglund C; Arola J
Hum Pathol; 2019 Apr; 86():66-75. PubMed ID: 30529752
[TBL] [Abstract][Full Text] [Related]
17. [Adrenocorticotropic hormone-secreting adrenal pheochromocytoma: a case report].
Tanikawa G; Ueda T; Nakamura Y; Hosomi M; Kirohara H
Hinyokika Kiyo; 2004 Oct; 50(10):691-4. PubMed ID: 15575219
[TBL] [Abstract][Full Text] [Related]
18. Adrenocorticotropic hormone-producing pheochromocytoma: a case report and review of the literature.
Li XG; Zhang DX; Li X; Cui XG; Xu DF; Li Y; Gao Y; Yin L; Ren JZ
Chin Med J (Engl); 2012 Mar; 125(6):1193-6. PubMed ID: 22613555
[TBL] [Abstract][Full Text] [Related]
19. Monoclonal antibodies against the human somatostatin receptor subtypes 1-5: development and immunohistochemical application in neuroendocrine tumors.
Schmid HA; Lambertini C; van Vugt HH; Barzaghi-Rinaudo P; Schäfer J; Hillenbrand R; Sailer AW; Kaufmann M; Nuciforo P
Neuroendocrinology; 2012; 95(3):232-47. PubMed ID: 22156600
[TBL] [Abstract][Full Text] [Related]
20. Production of immunoreactive corticotropin-releasing hormone in various neuroendocrine tumors.
Tsuchihashi T; Yamaguchi K; Abe K; Yanaihara N; Saito S
Jpn J Clin Oncol; 1992 Aug; 22(4):232-7. PubMed ID: 1359172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
